AnaptysBio (ANAB) announced that its board of directors has authorized an amended stock repurchase plan under which the company may repurchase up to $100M of the company’s outstanding common stock, par value $0.001 per share. This amendment is in addition to the $6.4M that remained as of Nov. 20 under the current $75M stock repurchase plan of which Anaptys has repurchased a total of 3,443,188 shares of common stock.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANAB: